Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz gmbh* - rifampicinum inn - hart hylki - 150 mg

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - linezolidum inn - innrennslislyf, lausn - 2 mg/ml

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - verapamilum hýdróklóríð - forðatafla - 120 mg

União Europeia - islandês - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Æxlishemjandi lyf - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

União Europeia - islandês - EMA (European Medicines Agency)

provepharm sas - metýlþíóníumklóríð - methemóglóbíndreyri - Öll önnur lækningavörur - bráð einkenni meðhöndlunar á methemóglóbíndreyri í lyfjum og efnaafurðum. methylthioninium i proveblue er ætlað í fullorðnir, börn og unglingar (aldrinum 0 til 17 ára).

União Europeia - islandês - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

União Europeia - islandês - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

h. lundbeck a/s* - chlorprothixenum hýdróklóríð - filmuhúðuð tafla - 50 mg

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

h. lundbeck a/s* - chlorprothixenum hýdróklóríð - filmuhúðuð tafla - 15 mg

Islândia - islandês - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - diltiazemum hýdróklóríð - forðatafla - 120 mg